CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
Authors
A Di Stasi
A Hombach
+55 more
B Savoldo
C Berger
C Colovos
C Schlimper
CA Klebanoff
CC Kloss
CH Lamers
Chun-rong Wang
CJ Shen
CJ Turtle
CU Louis
D Chinnasamy
DL Porter
DM Barrett
EJ Cheadle
Ethan Q Han
GJ McGarrity
HM Finney
J Scholler
JN Kochenderfer
JN Kochenderfer
JR Park
JS Bridgeman
L Gattinoni
L Gattinoni
LE Kandalaft
M Hudecek
M Kalos
MC Milone
ME Dudley
N Shirasu
PA Antony
R Brentjens
R Schroers
RA Morgan
RA Morgan
RD Guest
RJ Brentjens
RR Rao
S Tammana
SA Grupp
SA Rosenberg
Shuang-yin Han
SN Maiti
T Zhang
Tian-fang Li
TJ Curiel
V Russo
W Haso
X Wang
Xiu-ling Li
XJ Xu
Y Nakazawa
YM Mueller
Z Eshhar
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2F1756-8722-6...
Last time updated on 05/06/2019